Workshop

Online Workshop

April 28th 2021 - R&D Ecosystem
May 19th 2021 - Translational Ecosystems

Personalising Health Industry

Personalising Health Industry
Personalising Health Industry

Day 2, May 19th, 2021

Regional Translational Ecosystems Supportive of Personalising Health Industry

Bringing innovation from the R&D phase to the market requires translational and frequently also entrepreneurial efforts. However, to realize these has long been identified as a bottle-neck resulting in a valley of death for many projects. To pass this gap, it has been proposed and discussed, to reduce the risk profile of new ventures and translational activities by providing comprehensive early-stage support schemes and structures. De-risiking is also seen as an important strategy to counteract against the lack of risk capital availability throughout Europe. Though this idea is not entirely novel, as first business incubators for the life sciences were already set up in the late 90s in Europe, the concepts have been developed further and become more refined, and relevant expertise has grown as structures have institutionalised and professionalised.

 

Day 1, April 28th 2021

A Regional R&D Ecosystem for Personalising Health Industry – Spotlight on the Free State of Saxony

It is well recognised that a thriving R&D ecosystem is a facilitator and an important resource for innovation in almost any scientific field. The concept of R&D innovation ecosystem implies that academic R&D-related innovation potential feeds into industry and vice versa. Relations are manifold, with proximity and closer social contacts between actors and supporting structures ´such as tech transfer and cluster organisations serving as catalysers. These ecosystems may enhance industry development by providing essential R&D infrastructures for personalised medicine and health, as much as by generating qualified human resources. A well-functioning regional R&D ecosystem may offer high-tech services on one hand, and on the other guidance by generating role models for entrepreneurship and the translation of scientific breakthroughs into tangible innovative products.

 

The program of the Workshop is based on the Conference on “Personalising Health Industry” that was held in October 2020.

If you’d like to know what was discussed, the recordings of the event can be found right here:

 

https://www.youtube.com/playlist?list=PLouPT0Qs67pAx4tE-_ii6JSpJislDZIAm

 

 

#PersonalisingHealthIndustry #PersonalisedHealthcare #PersonalisedMedicine #EuropeanRegions

Programme

May 19th, Regional Translational Ecosystems Supportive of Personalising Health Industry

12.45

Check-in to Online System & Introduction to the System

13.00

Greetings from the European Commission

Jean-Luc Sanne – European Commission, Brussels (Belgium)

Cornel Riscanu – Health and Digital Executive Agency (HaDEA), Brussels (Belgium)

13.05

Introduction Regions4PerMed: the Project, Aim of the Workshop

Gianni D’Errico – Fondazione Toscana Life Sciences, Florence (Italy)

13.10

Health Industry Perspective on Regional Ecosystem Support

Introduction by Moderators:

Dr. André Hofmann – Biosaxony e.V.

Dr. Eva-Maria Stegemann – Saxon State Ministry for Science, Culture and Tourism

13.15

Needs of Pharmaceutical Entrepreneurs for Personalised Medicine

Alexander Natz – European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Brussels (Belgium)

13.25

A Pharmaceutical Industry Perspective on Personalised Medicine

Dr. Florian Puehler – Bayer AG, Berlin (Germany)

13.35

The Entrepreneurial Perspective on Translation in Practice – developing and bringing a PM Product to the Market

Dr. Sophie Raynal – Metabrain Research, Paris (France)

13.45

Q&A and Short Break 

14.00

Translational Ecosystem for Personalised Medicine & Health 

Introduction by Moderators:

Dr. André Hofmann – Biosaxony e.V.

Dr. Eva-Maria Stegemann – Saxon State Ministry for Science, Culture and Tourism

14.05

Navarra: European Entrepreneurial Region with a focus on Personalised Medicine

Prof. Felipe Prosper – Universidad de Navarra, Pamplona (Spain)

14.20

Bridging the Translation Gap for Personalised Medicine in Oncology

Dr. Andrée Rothermel – TRON – Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gGmbH, Mainz (Germany)

14.35

Supporting Cross Disciplinary On-Campus Networking for Digital Health Projects

Sabine Marschollek – Else Kröner Fresenius Center for Digital Health, Technische Universität Dresden, Dresden (Germany)

14.50

Codex4SMEs – Interregional Collaboration for Companion Diagnostics

Dr. Margot Jehle – BioRegion Stern, Stuttgart (Germany)

15.05

EIT Health – Pan-European Collaboration, Acceleration and Co-Investment

Dr. Katharina Ladewig – EIT Health Germany, Heidelberg (Germany)

15.30

Poll 

 

15.35

Plenary Discussion in light of Poll and Chat

All Speakers

16.10

Conclusions and Closing Remarks

16.15

End of Event

April 28th 2021, A Regional R&D Ecosystem for Personalising Health Industry - Spotlight on the Free State of Saxony

12.45

Check-in to Online System & Introduction to the System

13.00

Host Greetings from the Free State of Saxony

Sebastian Gemkow – Saxon Ministry for Science, Culture and Tourism, Dresden (Germany)

13.05

Introduction Regions4PerMed: the Project, Aim of the Workshop

Gianni D’Errico – Coordinator of Regions4PerMed, Fondazione Toscana Life Sciences, Florence (Italy)

Health Industry Perspective on Regional R&D Ecosystems for Personalised Medicine and Health

Introduction by Moderators:

Dr. Olaf Müller – Carus Consilium Sachsen GmbH

Dr. Eva-Maria Stegemann – Saxon State Ministry for Science, Culture and Tourism

13.10

ATMP – Regional Aspects in R&D Ecosystems to consider

Dr. Thorsten Ruppert –  vfa, Frankfurt (Germany)

13.20

What makes a Region attractive for an established Large Player with an interest in Personalised Health and ATMP

Oliver Stenzel – Novartis Deutschland GmbH, Berlin (Germany)

13.30

vita 34 AG – Entrepreneurship in the Regional R&D Ecosystem of the Free State of Saxony

Dr. Wolfgang Knirsch – vita 34 AG, Leipzig (Germany)

13.40

Q&A and Short Break

Elements of the R&D Innovation Ecosystem for Personalised Medicine & Health in the Free State of Saxony

Introduction by Moderators:

Dr. Olaf Müller – Carus Consilium Sachsen GmbH

Dr. Eva-Maria Stegemann – Saxon State Ministry for Science, Culture and Tourism

14.00

SaxoCell – Expanding and Developing Regional Strengths in the field of ATMP through Collaboration

Prof. Ulrike Köhl – Fraunhofer Institute For Cell Therapy and Immunology, Leipzig (Germany)

14.15

Coordinating Research in the Field of Myelodysplastic Syndromes (MDS) – EMSCO and D-MDS

Prof. Uwe Platzbecker – Medical Clinic and Polyclinic for Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig (Germany)

14.30

GWT-TUD – Providing Services for R&D in the Medical Field

Prof. Jacques Rohayem – GWT-TUD GmbH, Dresden, (Germany)

14.45

SaxoChiLD – Regional Collaboration on Child Health and Development in a National Context

Prof. Antje Körner – Department of Pediatrics, Medical Faculty, Leipzig (Germany)

15.00

ERA PerMed – Coordinating Research in Personalised Medicine and Health across Borders

Dr. Cristina Nieto – National Health Institute Carlos III, Madrid (Spain)

15.10

Plenary Discussion in light of Poll and Chat

All Speakers

Dr. Monika Frenzel – The French National Research Agency, Paris (France)

Prof. Michael Bachmann – Helmholtz Centre Dresden Rossendorf, Dresden (Germany)

15.25

Plenary Discussion

All Speakers

15.45

Conclusions/Closing remarks

Gianni D’Errico – Coordinator of Regions4PerMed, Fondazione Toscana Life Sciences, Florence (Italy)

16.00

End of Event